The Food and Drug Administration (FDA), in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices Portal System – an online platform for FDA marketing authorization applications.
The FDA wishes to invite stakeholders to use the FDA eServices Portal System through eservices.fda.gov.ph for the applications for Compassionate Special Permit. The eServices Portal is in its Pilot Implementation; hence the scope of the application is limited for the time being:
| FDA eServices Portal Pilot Implementation
for Compassionate Special Permit |
|
| Transactions | Compassionate Special Permit (Named Patient Use)
Compassionate Special Permit (Institutional Use) |
| Fees to be Paid | Based on Current Issuance on Fees and Charges (DOH Administrative Order No. 50, s. 2001) |
| Start of Pilot Implementation | 19 November 2020 |
| End of Pilot Implementation | 19 December 2020 |
Please follow Annex A of this Advisory for the Guideline and Checklist of Requirements, Annex B for step-by-step guide, and Annex C for checking of application status via FDA eServices Portal System.
For any feedback and comments for the FDA eServices Portal System, please send it to [email protected].
Read more:->FDA ADVISORY NO. 2020-2013
